Deerfield Management as of Dec. 31, 2013
Portfolio Holdings for Deerfield Management
Deerfield Management holds 99 positions in its portfolio as reported in the December 2013 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Dendreon Corp note | 6.0 | $116M | 184M | 0.63 | |
Questcor Pharmaceuticals | 5.7 | $109M | 2.0M | 54.45 | |
Cubist Pharmaceuticals | 5.0 | $96M | 1.4M | 68.87 | |
Auxilium Pharmaceuticals | 4.4 | $85M | 4.1M | 20.73 | |
Humana (HUM) | 3.7 | $72M | 695k | 103.22 | |
Volcano Corporation note 1.750%12/0 | 3.1 | $60M | 61M | 0.99 | |
Infinity Pharmaceuticals (INFIQ) | 3.0 | $58M | 4.2M | 13.81 | |
Array BioPharma | 2.9 | $56M | 11M | 5.01 | |
NxStage Medical | 2.9 | $56M | 5.6M | 10.00 | |
Nuvasive Inc. conv | 2.4 | $46M | 42M | 1.08 | |
Antares Pharma | 2.4 | $45M | 10M | 4.47 | |
Integra Lifesciences Holdings conv bnd | 2.3 | $44M | 42M | 1.07 | |
Hologic Inc cnv | 2.0 | $38M | 38M | 1.02 | |
Intermune Inc note 2.500% 9/1 | 1.9 | $37M | 42M | 0.89 | |
Merck & Co (MRK) | 1.9 | $36M | 725k | 50.05 | |
D Horizon Pharma | 1.8 | $35M | 4.6M | 7.62 | |
Flamel Technologies | 1.8 | $35M | 4.3M | 8.05 | |
Globus Med Inc cl a (GMED) | 1.8 | $34M | 1.7M | 20.18 | |
Capital Senior Living Corporation | 1.8 | $34M | 1.4M | 23.99 | |
Universal American | 1.7 | $34M | 4.6M | 7.30 | |
Exelixis Inc cnv | 1.6 | $31M | 25M | 1.23 | |
DaVita (DVA) | 1.6 | $31M | 485k | 63.37 | |
Tornier Nv | 1.5 | $28M | 1.5M | 18.79 | |
XOMA CORP Common equity shares | 1.3 | $26M | 3.8M | 6.73 | |
Dyax | 1.3 | $25M | 3.4M | 7.54 | |
Array Biopharma Inc note 3.000% 6/0 | 1.2 | $24M | 23M | 1.04 | |
Accuray Inc Del note 3.750% 8/0 | 1.2 | $24M | 21M | 1.12 | |
Mylan | 1.2 | $23M | 532k | 43.40 | |
Pacific Biosciences of California (PACB) | 1.2 | $23M | 4.4M | 5.23 | |
Aetna | 1.2 | $22M | 327k | 68.59 | |
Molina Healthcare (MOH) | 1.2 | $22M | 645k | 34.75 | |
Air Methods Corporation | 1.1 | $22M | 370k | 58.26 | |
XenoPort | 1.1 | $21M | 3.7M | 5.75 | |
Portola Pharmaceuticals | 1.1 | $21M | 826k | 25.75 | |
Spectrum Pharmaceuticals | 1.1 | $21M | 2.4M | 8.85 | |
Momenta Pharmaceuticals | 1.0 | $20M | 1.1M | 17.68 | |
Keryx Biopharmaceuticals | 1.0 | $19M | 1.5M | 12.95 | |
Centene Corporation (CNC) | 1.0 | $18M | 313k | 58.95 | |
Brookdale Senior Living note | 1.0 | $19M | 16M | 1.20 | |
Insmed (INSM) | 0.9 | $18M | 1.1M | 17.00 | |
Allergan | 0.9 | $17M | 152k | 111.08 | |
Prosensa Hldgs B V Shs Usd | 0.8 | $15M | 3.1M | 4.67 | |
Sequenom Inc. note 5.000 10/0 | 0.8 | $15M | 17M | 0.86 | |
Teva Pharmaceutical Industries (TEVA) | 0.7 | $14M | 355k | 40.00 | |
Dendreon Corp cnv | 0.7 | $14M | 15M | 0.96 | |
Prothena (PRTA) | 0.7 | $14M | 529k | 26.52 | |
DepoMed | 0.7 | $13M | 1.3M | 10.58 | |
Integra LifeSciences Holdings (IART) | 0.7 | $13M | 272k | 47.71 | |
Nanosphere | 0.6 | $11M | 4.7M | 2.29 | |
Nanostring Technologies (NSTGQ) | 0.6 | $11M | 625k | 17.24 | |
BioDelivery Sciences International | 0.5 | $10M | 1.8M | 5.89 | |
Itmn 2 1/2 12/15/17 | 0.5 | $10M | 7.5M | 1.37 | |
Mei Pharma | 0.5 | $10M | 1.3M | 8.01 | |
Ptc Therapeutics I (PTCT) | 0.5 | $9.2M | 545k | 16.97 | |
Zogenix | 0.5 | $8.8M | 2.6M | 3.44 | |
Bluebird Bio (BLUE) | 0.5 | $8.9M | 423k | 20.98 | |
Accuray Inc note 3.500% 2/0 | 0.5 | $8.7M | 5.0M | 1.73 | |
Discovery Laboratories | 0.4 | $8.2M | 3.7M | 2.25 | |
Foundation Medicine | 0.4 | $8.2M | 346k | 23.82 | |
Vanda Pharmaceuticals (VNDA) | 0.4 | $7.8M | 631k | 12.41 | |
Alphatec Holdings | 0.4 | $8.0M | 4.0M | 2.01 | |
Baxter International (BAX) | 0.4 | $7.1M | 103k | 69.55 | |
Arena Pharmaceuticals | 0.4 | $7.1M | 1.2M | 5.85 | |
BioCryst Pharmaceuticals (BCRX) | 0.3 | $6.6M | 869k | 7.60 | |
Alere Inc note 3.000% 5/1 | 0.3 | $6.4M | 5.8M | 1.12 | |
Liposcience | 0.3 | $5.9M | 1.4M | 4.25 | |
Ovascience | 0.3 | $5.5M | 606k | 9.14 | |
CAS Medical Systems | 0.3 | $5.4M | 3.2M | 1.70 | |
Aerie Pharmaceuticals | 0.3 | $5.4M | 300k | 17.96 | |
Anthera Pharmaceutcls | 0.3 | $5.2M | 1.7M | 3.07 | |
Geron Corporation (GERN) | 0.2 | $4.7M | 1.0M | 4.74 | |
Cancer Genetics | 0.2 | $4.9M | 354k | 13.78 | |
Sunshine Heart | 0.2 | $4.2M | 432k | 9.71 | |
Cempra | 0.2 | $3.8M | 310k | 12.39 | |
Bind Therapeutics | 0.2 | $3.9M | 256k | 15.09 | |
LCA-Vision | 0.1 | $2.9M | 731k | 3.90 | |
Auxilium Pharmaceuticals note | 0.1 | $2.8M | 2.5M | 1.11 | |
Ocera Therapeutics | 0.1 | $2.7M | 211k | 12.99 | |
Targacept | 0.1 | $2.6M | 617k | 4.15 | |
Kindred Biosciences | 0.1 | $2.5M | 225k | 11.17 | |
Streamline Health Solutions | 0.1 | $2.3M | 325k | 6.98 | |
Albany Molecular Resh Inc note 2.250%11/1 | 0.1 | $2.4M | 2.6M | 0.93 | |
Rigel Pharmaceuticals | 0.1 | $2.2M | 764k | 2.85 | |
Novadaq Technologies | 0.1 | $2.0M | 120k | 16.49 | |
Palatin Technologies | 0.1 | $1.5M | 2.0M | 0.73 | |
Arrowhead Research | 0.1 | $1.5M | 142k | 10.85 | |
HMS Holdings | 0.1 | $1.3M | 58k | 22.70 | |
Amgen (AMGN) | 0.1 | $1.1M | 10k | 114.10 | |
Sunesis Pharmaceuticals | 0.1 | $1.2M | 250k | 4.74 | |
Endocyte | 0.1 | $1.2M | 112k | 10.68 | |
ArthroCare Corporation | 0.0 | $805k | 20k | 40.25 | |
BioScrip | 0.0 | $518k | 70k | 7.40 | |
Mast Therapeutics | 0.0 | $675k | 1.5M | 0.46 | |
Select Medical Holdings Corporation (SEM) | 0.0 | $341k | 29k | 11.60 | |
Imris (IMRSQ) | 0.0 | $305k | 192k | 1.59 | |
Hca Holdings (HCA) | 0.0 | $477k | 10k | 47.70 | |
Biotelemetry | 0.0 | $437k | 55k | 7.95 | |
Orexigen Therapeutics | 0.0 | $122k | 22k | 5.62 | |
Bacterin Intl Hldgs | 0.0 | $196k | 392k | 0.50 |